NeoALTTO(a)_2D | R Documentation |
Kaplan-Meier digitized data from NeoALTTO(a), figure 2D (PMID 25130998). A reported sample size of 455 for a primary endpoint of pCR in breast cancer.
`NeoALTTO(a)_2D`
A data frame of 303 observations and 3 variables:
time | event time (in years) | |
event | OS event indicator (0 : no event, 1 : event) |
|
arm | treatment arms (l, t) | |
de Azambuja E, Holmes AP, Piccart-Gebhart M, et al. Lapatinib with trastuzumab for HER2-positive early breast cancer (NeoALTTO): survival outcomes of a randomised, open-label, multicentre, phase 3 trial and their association with pathological complete response. Lancet Oncol 2014; 15: 1137–46.
summary(`NeoALTTO(a)_2D`)
kmplot(`NeoALTTO(a)_2D`)
Add the following code to your website.
For more information on customizing the embed code, read Embedding Snippets.